Stay updated with breaking news from Concert risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
anger and uncertainty had buyer s annual meeting putting the german chemical giant on the defensive the legal troubles of its recent acquisition monsanto have shareholders up in arms. and u.s. first quarter economic growth beats all expectations but investors were missed in their response the financial correspondent tells us why. also on the show japan has a notorious work till you drop business culture or the country s labor shortage is now giving workers in one sector some leverage to challenge those expectations to give the details. and student peers in berlin thanks for joining us german chemical multinational buyer faces shareholders at the group s annual meeting friday in bonn and as expected it was a tense affair the company s share price has lost nearly half its value following last year s takeover of u.s. agra tech for months and in particular after two american court cases linked that company s popular weed killer round up to cancer cases and that s put buyer in the ....
There are unsettling many people. or feel them and. they re also unsettled by a number of studies the world health organization says and one that glyphosate is a potential concert risk while other scientists concludes that guy for ses is not carcinogenic one thing is certain the destruction of buyers market caps and the monsanto acquisition as its stock price collapses there s deep mistrust of the company both inside and outside of the pond missing right now the value of what was once germany s most valuable listed chemical company is only around fifty seven billion euros which is pretty much exactly what buyer paid for months on tow over to the u.s. which has posted its strongest first quarter growth in four years economy expanded three point two percent far exceeding expectations and bucking a global trends of negative economic indicators the growth was driven largely by an ....
Along to let the board know what they think. you should have to say i m a bit shaken by this when you buy shares in a company that i know the risks i have my doubts whether mr bollen can do us. to do something like that he s in comprehensible buyer s chief executive in about a month who spearheaded the purchase of us biotech firm monsanto last year was defiant defending the takeover as the right move however the company currently faces thousands of lawsuits in the u.s. over possible cancer risks. there s no way to gloss this over the lawsuits and the initial verdicts on life a safe have weighed heavily on our company and there unsettling many people the four winds of freedom and. they re also unsettled by a number of studies the world health organization says and one that glyphosate is a potential concert risk while other scientists concludes that guy for sage is not ....
Claims that it could be carcinogenic. this week the european union postponed a decision on whether to allow farmers to continue to use the weed killer at the conclusion of the meeting no vote was taken the commission took note of the position of different delegations of member states with no reflect outside environmental activists expressed their attitude in no uncertain terms they accuse european authorities of being in bed with pharmaceutical companies so these don t agree on whether glyphosate poses a concert risk or not the world health organization has said it could pose a danger the e.u. food safety authority says it s harmless but members of the green party in the european parliament say more impartial studies are needed. we need to look at independent studies not just ones carried out by the industry we have to finally end this thing with life assess there are standard farming methods ....